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OBJECTIVES: To evaluate the clinical response and success rate after periuterine varices embolization in patients
with chronic pelvic pain secondary to pelvic congestion syndrome and to report the safety of endovascular
treatment and its rate of complications.
METHODS: Retrospective cohort of patients undergoing endovascular treatment of pelvic congestion syndrome
in our department from January 2012 to November 2015. Data were analyzed based on patient background,
imaging findings, embolized veins, rate of complications, and clinical response as indicated by the visual analog
pain scale.
RESULTS: We performed periuterine varices embolization in 22 patients during the study, four of which
required a second embolization. Seventeen patients reported a reduction in pelvic pain after the first
embolization and three patients reported a reduction in pelvic pain after the second embolization. Minor
complications were observed in our patients, such as postural hypotension, postoperative pain, and venous
perforation during the procedure, without clinical repercussion.
CONCLUSION: Periuterine varices embolization in patients with chronic pelvic pain secondary to pelvic
congestion syndrome appears to be an effective and safe technique.
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’ INTRODUCTION
Chronic pelvic pain (CPP) is defined as frequent, non-cyclical
pelvic pain of at least 6 months duration and affects appro-
ximately one-third of patients seeking gynecological care. CPP
has an extremely negative impact on quality of life (1,2).
Pelvic congestion syndrome (PCS) is caused by pelvic
venous insufficiency with retrograde flow in incompetent
veins, usually the left ovarian vein, and development of
pelvic varicosities (1). Similar to varicose veins in the lower
limbs, these varicosities are due to a combination of incom-
petent venous valves, retrograde blood flow, and venous
dilation. The symptoms are understood as a result of venous
filling of varicose veins by a gravitational effect, and classical
clinical presentations are pelvic or back pain that tends to
worsen with standing and physical activity or in the late
afternoon and is exacerbated before periods and after sexual
intercourse (3). Pelvic varicosities and CPP are hallmark
features of PCS, but women diagnosed with pelvic varicose
veins can be asymptomatic (4).
The disease affects primarily multiparous patients of
reproductive age for whom other causes of chronic pain
must be excluded, such as infections, endometriosis, atypical
menstrual pain, pelvic postoperative adhesions, pelvic infla-
mmatory disease, and urological, musculoskeletal, psychia-
tric, and intestinal disorders (5).
In PCS, we find insufficiency in the left ovarian vein,
presumably because its junction with the left renal vein
forms a right angle, facilitating reflux. There are associations
with mechanical compression, such as nutcracker andDOI: 10.6061/clinics/2016(12)05
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May-Thurner syndromes (7,8). The diagnosis of pelvic
venous insufficiency is made by imaging studies, such as
pelvic ultrasound with Doppler, pelvic computed tomogra-
phy (CT), pelvic magnetic resonance (MR), laparoscopy, and
transcutaneous venography. The latter is considered the gold
standard in this field (9,10,11).
There are several treatment modalities for PCS, including
drug therapy (7), surgical options such as hysterectomy with
unilateral or bilateral oophorectomy and vein ligation, and
endovascular treatment (11,12).
A few decades ago, endovascular treatment was proposed
as an alternative treatment for PCS. The technique consists of
accessing the pelvic veins and identifying the venous insuf-
ficiency by venography; then, embolization materials (metal
coils or sclerosing agents) are placed to cause permanent
occlusion and thrombosis of the territory. After occlusion of
the insufficient veins, blood flow is diverted by the pelvic
anastomotic network to drain the remaining veins, usually
for the internal iliac veins. Endovascular treatment is mini-
mally invasive and is performed under local anesthesia, thus
enabling faster recovery for patients and shorter hospital
stays (11,13-17). Despite the widespread use of the endovas-
cular technique, published studies have used small samples
with extensive technical variability and varying relationships
between factors involved in the success or failure of clinical
response.
Additionally, the clinical benefits of endovascular treatment
have not yet been demonstrated in the Brazilian population.
Thus, the aim of this study was to evaluate the efficacy and
safety of endovascular treatment of PCS in a Brazilian medical
institution.
’ MATERIALS AND METHODS
This was a retrospective cohort from one center, with data
evaluation of women treated in our medical institution. Data
were analyzed in patients with CPP secondary to PCS who
underwent endovascular treatment from January 2012 to
November 2015, with a minimum follow-up of three months
until March 2016. Patients with clinical suspicion of PCS who
underwent venography without venous insufficiency and
thus did not undergo embolization were excluded.
The following information was collected: age at diagnosis,
time of symptoms, parity, history of pelvic surgeries, peri-
uterine vein diameters visualized on MR before and after the
procedure, reflux parameters in time-resolved magnetic
resonance angiography (TR-MRA), and diagnostic venogra-
phy, including embolized veins at the procedure.
The analysis of the TR-MRA and venographies invol-
ved the left ovarian vein reflux classification proposed by
Hiromura in 2004 and was divided into three grades of reflux
(Figure 1): grade I corresponding to confined reflux in the
left ovarian vein, grade II corresponding to reflux reaching
the ipsilateral periuterine venous plexus, and grade III
corresponding to reflux crossing the midline and reaching
the contralateral periuterine venous plexus (18).
Pain intensity was based on the visual analog pain scale
(VAPS) and was assessed before and after the endovascular
procedure, with reassessment after treatment (varying from 3
to 24 months). This scale was chosen due to its wide use for
the clinical evaluation of pain syndromes (19). Technical
success was defined as the absence of venous reflux at post-
embolization venography, and clinical success was defined
as pain reduction during follow-up.
In accordance with the multidisciplinary strategy of care
at our institution, CPP patients in the Gynecology and
Obstetrics service underwent detailed clinical and laboratory
evaluations, including a physical exam, transvaginal ultra-
sound, urinalysis, urine culture and, less frequently, MR,
urodynamics, cystoscopy, hysteroscopy and/or laparoscopy
to highlight their main issues. Patients with CPP suspected to
be secondary to CPS (with persistent pain even after drug
treatment) were then referred to Interventional Radiology.
Patients with both clinical suspicion and limiting pain
underwent venography regardless of confirmation of diag-
nosis by MR.
Figure 1 - Venography of three different patients, exemplifying reflux grades. (a) Selective left renal venography shows confined reflux
in the left ovarian vein corresponding to grade I reflux. (b) Left ovarian venography shows reflux in the dilated left ovarian vein and
periuterine veins corresponding to grade II reflux. (c) Left ovarian venography shows a dilated left ovarian vein and periuterine reflux
extending across the midline (grade III reflux). Note the contrast material reaching the contralateral ovarian vein (arrow).
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Procedures
All periuterine varices embolization (PVE) procedures
were performed under conscious sedation and/or spinal
anesthesia, without the use of heparin. The first emboliza-
tion protocol consisted of right femoral vein puncture,
followed by catheterization of the left ovarian vein with 5F
diagnostic catheters (Simmons/Sidewinder 1, Cobra 1 or
Cobra 2). When venous insufficiency of the left ovarian vein
was confirmed, embolization of this vessel was performed
with 0.035-inch fibered coils (VortX pushable Coils, Boston
Scientific, USA) until occlusion occurred (Figure 2). The
catheterization of other pelvic veins was not conducted
unless left ovarian vein reflux was not present or another
pelvic vein reflux was observed in previous TR-MRA.
Second embolization, if necessary, was performed by
femoral or jugular vein puncture, followed by complete
pelvic venography with the aid of diagnostic catheters 5F
(vertebral, Simmons/ Sidewinder 1, Cobra 1 or Cobra 2). If
an insufficient vein was present, we performed embolization
with fibered coils until its occlusion.
After the procedure, patients remained in post-anesthesia
observation and were discharged the same day or remained
hospitalized for one day, depending on the time of the day
the procedure was performed and how far the patient lived
from the hospital. All patients were instructed about symp-
toms of pain during the first week post-procedure and were
prescribed analgesics, nonsteroidal anti-inflammatories, and
opioid drugs if necessary.
Statistical analysis
Statistical analysis was performed by an independent,
blinded statistician using IBM SPSS Statistics 20. Categorical
variables are presented as numbers and percentages and
were studied in terms of distribution frequency and com-
pared among groups using the Chi-square or Fisher’s exact
test, as appropriate. Quantitative variables are presented as
the mean, and the Mann-Whitney or Student’s t-test was
used as appropriate. A p value of less than 0.05 was defined
as significant.
Ethics
This study received approval from the local Research
Ethics Committee.
’ RESULTS
Twenty-seven patients underwent venography from
January 2012 to November 2015, and PVE was performed
in 22 patients. Five patients were excluded because they did
not show venous insufficiency at venography and thus PVE
was not performed. The age at treatment ranged from 29 to
55 years (mean 38.4 years, SD 6.9), with a time frame of
symptoms from 6 to 216 months (mean 59.6 months, SD
48.6). Seven patients (31.8%) who underwent PVE were
postmenopausal. Parity ranged from 0–7, with only one
nulliparous patient. Fourteen patients had previous pelvic
surgery, and 13 of those included Cesarean section. Laparo-
scopy (n=5), resection of endometriomas (n=2), salpingect-
omy (n=3), salpingo-oophorectomy (n=1), hysterectomy
(n=1), tubal ligation (n=2), and bladder sling (n=1) summar-
ize the cases of previous pelvic surgery.
Embolization of the left ovarian vein was performed in
21 patients (one patient underwent embolization of the
internal iliac veins). In three cases, 2 veins were embolized
during the procedure: the left internal iliac in one case, the
right ovarian vein in another, and both internal iliac veins in
the third case. Minor complications were observed in 4 cases,
including 2 cases of venous rupture without symptoms or
rebound hemoglobin levels, a case of limiting pelvic pain
until the eighth postoperative day, and one case of postural
hypotension in the first postoperative day. No cases of coil
migration, bleeding with hemodynamic repercussion, con-
trast reactions, or death were reported. Individual patient
data are shown in Table 1.
Figure 2 - Embolization technique. (a) Venography pre-embolization with reflux in the left ovarian vein to periuterine veins. (b) Left
ovarian vein catheterization to its distal segment using angiographic catheter over a hydrophilic guide wire. (c) Radiography after
embolization, showing fibered metallic coils from the distal segment of the left ovarian vein to its proximal third. (d) Venography post-
embolization, with complete occlusion of the vessel. Note the contrast material only in the proximal segment of the left ovarian vein
(arrow).
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A second embolization was performed in 4 patients, with
embolization of both ovarian veins in 2 of these patients: the
two internal iliac veins in 1 patient and only the right ovarian
vein in the other. One of these patients had limiting pelvic
pain until the 15th postoperative day. All procedures demon-
strated technical success.
The VAPS average before the procedure was 8.4 and
decreased to 5.2 after the procedure, with the evaluation time
post-procedure ranging from 3 to 24 months (mean 10.2
months, median 6.0 months, SD 7.9). Symptoms improved
in 17 cases (77.3%). In retreatment cases, three patients showed
improvement in symptoms (75%).
One case of clinical failure showed marked improvement
(VAPS from 10 to 1) after laparotomy with lysis of abdo-
minopelvic adhesions. Another case of clinical success with
PVE while maintaining significant symptoms showed impro-
vement (VAPS went from 7 to 0) after laparoscopy, with
excision of a rectovaginal septum endometrioma.
Pelvic MR was performed before the procedure in 21 of
22 patients, and the diameter of periuterine veins ranged
from 3 to 10 mm (average 6.7 mm, SD 1.6). Post-treatment
pelvic MR was performed in 13 patients at times ranging
from 4 to 35 months after the procedure; one patient did
not undergo MR before the procedure. The diameter of
the periuterine veins in post-treatment MR ranged from 2 to
7 mm, with diameter reduction occurring in eight cases
(66.7%). In 12 patients, measurement of periuterine veins
(both pre- and post-embolization) by pelvic MR revealed that
the average diameter of periuterine veins was 6.5 mm before
PVE and 4.8 mm after PVE (p=0.015). Clinical and procedural
data can be found in Table 2.
TR-MRA was performed in 20 patients before PVE, and
incorrect technique was used in 4 cases (images were acqui-
red only in the arterial phase). Of the remaining cases, 14 had
positive findings for reflux in the left ovarian vein; the Hiro-
mura reflux classification was grade I for 6 cases, grade II for
4 cases, and grade III for 4 cases. Venography (performed in
all 22 patients) showed left ovarian vein reflux in 21 patients,
which was grade I in 3 cases, grade II in 13 cases, and grade
III in 5 cases. The correlation of the presence of left ovarian
vein reflux between TR-MRA and venography was 87.5%,
whereas Hiromura reflux grade compatibility in that vessel
between the methods was observed only in 7 cases (50%).
The imaging and procedural data are presented in Table 3.
Comparing reflux grade with the clinical response, the
five cases with grade III left ovarian vein reflux on veno-
graphy exhibited symptom improvement after endovascular
Table 1 - Individual characteristics of the patients.
Patient (n) Age Parity (n) Previous pelvic
surgeries
Time from symptoms to
embolization (weeks)
VAPS before/after
embolization
Time from
embolization to
VAPS (months)
Minor
complications
1 29 1 N 24 10 / 4 24 N
2 37 2 Y 96 10 / 7 24 N
3 32 3 N 36 7 / 2 3 N
4 34 2 Y 18 10 / 3 6 N
5 41 3 N 84 4 / 1 24 N
6 37 7 Y 36 9 / 7 6 N
7 55 4 Y 84 8 / 4 3 N
8 46 2 Y 48 10 / 8 6 N
9 38 2 Y 60 7 / 4 24 N
10 30 1 Y 72 9 / 9 9 N
11 48 3 Y 48 8 / 6 10 N
12 45 1 Y 36 9 / 0 6 Y
13 42 1 Y 16 7 / 6 7 N
14 44 1 Y 156 9 / 2 24 Y
15 34 2 Y 6 8 / 10 3 N
16 29 2 Y 216 10 / 1 6 N
17 37 2 N 24 6 / 5 6 N
18 35 5 N 36 10 / 10 10 Y
19 34 0 N 84 8 / 1 6 Y
20 30 1 N 36 9 / 6 3 N
21 44 2 Y 36 7 / 8 9 N
22 44 3 N 60 10 / 10 6 N
Legend: (VAPS) Visual analog pain scale; (Y) Yes; (N) No.
Table 2 - Clinical and procedural data.
Results
n=22
Time from symptoms to embolization
(weeks) (mean, range, SD)
59.6 (6-216, 48.6)
VAPS before embolization
(mean, range, SD)
8.4 (4-10, 1.6)
VAPS after embolization
(mean, range, SD)
5.2 (0-10, 3.2)
Time from embolization to VAPS (months)
(mean, range, SD)
10.2 (3-24, 7.9)
Symptom improvement after
embolization (n, %)
17 (77.3)
Minor complications (n, %) 4 (18.2)
n=21
Diameters of periuterine veins
(mm) on MR before embolization
(mean, range, SD)
6.7 (3-10, 1.6)
n=13
Diameters of periuterine veins
(mm) on MR after embolization
(mean, range, SD)
4.9 (2-7, 1.5)
n=12
Reduction of periuterine vein
diameter after embolization (n, %)
8 (66.7)
Legend: (VAPS) Visual analog pain scale; (SD) Standard deviation; (MR)
Magnetic resonance; (N) Patient number.
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treatment (clinical success of 100%), whereas symptom imp-
rovement was observed in only 11 of 16 cases with reflux
ranging between I and II in the left ovarian vein (a clinical
success rate of 68.7%), but this result was not significant
(p=0.27).
’ DISCUSSION
PCS is a pathological condition causing chronic pain that
usually affects young patients, with a high incidence of
anxiety, depression, and sexual disorders (1,2). Treatment of
this condition greatly improves patient quality of life.
Treatment of CPP secondary to PCS can be accomplished
with hormonal therapy, surgical procedures, or embolization.
Medical management can be achieved with medroxyproges-
terone acetate or analogues of gonadotropin-releasing hor-
mone (goserelin acetate), resulting in improvement of symp-
toms for up to four months that is not sustained long-term
(7). As a surgical alternative, hysterectomy with unilateral or
bilateral oophorectomy was reported to improve symptoms
in up to two-thirds of patients after one year of clinical follow-
up (20), whereas other studies did not show significant
pain reduction (17). Failure of symptom improvement after
hysterectomy may be due to the rich anastomotic periuterine
network, which makes it more difficult to complete resection
during surgery. Surgical risks, sterilization, and unsatisfactory
results after hysterectomy, associated with the availability of
less invasive methods, have eliminated hysterectomy as the
first option for treatment. In 2003, Chung and Huh compared
three treatment options for CPP secondary to PCS (PVE; hys-
terectomy with bilateral oophorectomy and hormone replace-
ment; and hysterectomy with unilateral oophorectomy), with
clinical results statistically favorable to PVE (12). Venous
ligation of one or both ovarian veins has also been proposed as
a treatment (11) but is rarely performed. The endovascular
technique, which involves a shorter procedure time and faster
postoperative recovery, is preferable to that of venous ligation
(11). Various embolizing materials are used in the endovas-
cular technique, including liquid sclerosing agents and
metallic coils, and no significant differences in clinical
outcomes were observed among the embolizing materials
(1,2,11,13-17). In our study, all embolizations were performed
with fibered metallic coils.
In our institution, we performed a different treatment pro-
tocol from that frequently found in the literature. Whereas
pre-embolization venography involves the study of two
gonadal veins, including the study of the internal iliac veins
(1,2,7,13-16,21-23), the left ovarian vein was studied in
patients with CPP who submitted to venography in our
institution. The catheterization of other pelvic veins was not
conducted unless left ovarian vein reflux was not confirmed
or another pelvic vein reflux was identified in previous
TR-MRA. This approach was based on the increased inci-
dence of reflux in the left ovarian vein and reduced radiation
exposure and the use of contrast material.
The overall clinical success rate of 76.9% is consistent with
values reported in the literature of 60 to 100% (1,2,7,13-17,21-
23), with significant pain reduction indicated by VAPS along
with a reduction in the average periuterine vein diameters as
determined by MR. In two patients (9%), we identified a
concomitant cause of CPP after the performance of PVE.
A tendency toward a better clinical response was observed
in patients classified as having grade III reflux by the
Hiromura classification; however, the result was not sig-
nificant (p=0.27).
During the evaluation period, 4 of 22 (18.2%) patients
required retreatment, with reflux identification in veins other
than the left ovarian vein in the second embolization. There-
fore, the retreatment rate was attributed to a simplified initial
venography protocol.
Table 3 - Patient radiological and procedural data.
Patients
(n)
Periuterine vein diameter
before/after embolization (mm)
Reflux grade of the left ovarian vein
based on TR-MRA/venography*
Embolization sessions
(n)/Veins occluded (n)
Veins occluded Symptom
improvement after
embolization
1 6 / 6 NA / 0 1 / 2 RIV, LIV Y
2 8 / 4 III / III 1 / 1 LOV Y
3 8 / 7 I / II 1 / 1 LOV Y
4 7 / 3 III / III 1 / 1 LOV Y
5 10 / 6 NA / II 1 / 1 LOV Y
6 7 / 4 NA / II 2 / 2 LOV, ROV Y
7 8 / NA I / II 2 / 2 LOV, ROV Y
8 7 / NA I / III 1 / 1 LOV Y
9 5 / 6 III / II 1 / 1 LOV Y
10 3 / 4 II / II 1 / 1 LOV N
11 7 / NA NA / II 1 / 1 LOV Y
12 5 / 2 NA / II 1 / 1 LOV Y
13 5 / NA II / II 1 / 1 LOV Y
14 6 / NA I / I 1 / 1 LOV Y
15 9 / NA NA / II 1 / 1 LOV N
16 5 / NA I / II 1 / 1 LOV Y
17 NA / 5 NA / III 2 / 3 LOV, RIV, LIV Y
18 5 / 5 I / II 2 / 2 LOV, ROV N
19 7 / 5 III / III 1 / 1 LOV Y
20 8 / 7 0 / I 1 / 2 LOV, ROV Y
21 8 / NA II / II 1 / 2 LOV, LIV N
22 8 / NA II / I 1 / 1 LOV N
Legend: (NA) Not available; (0) absence of reflux; (TR-MRA) Time-resolved magnetic resonance angiography; (ROV) Right ovarian vein; (LOV) Left ovarian
vein; (RIV) Right iliac vein; (LIV) Left iliac vein; (Y) Yes; (N) No.
*Hiromura reflux classification.
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Minor and transient complications such as postural
hypotension, limiting postoperative pain and venous rupture
during the procedure without clinical repercussions were
identified in 18.2% of cases. There were no permanent com-
plications or death, consistent with literature descriptions
(1,2,7,13-17,21-23). Coil migration, described at a 1.6% rate in
the literature, was not observed in this study.
Our study has several limitations. First, it was a retro-
spective observational study and included a small number
of patients, which prevents additional statistical analysis.
Second, in our study, patients experienced variability in
access time to the VAPS. Finally, the adjuvant treatment of
patients included heterogeneous use of antidepressants,
anxiolytics, and hormonal therapy with progestin, which
eventually could represent a bias for evaluation of clinical
response. A multicenter controlled study must be performed
to confirm our findings.
In conclusion, the findings of this study suggest that PVE
in patients with CPP secondary to PCS is a feasible and
effective method to improve CPP symptoms and can be
considered a valid therapeutic strategy for this Brazilian
subpopulation.
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